12:00 AM
Aug 20, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lomitapide regulatory update

FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Oct. 17 to discuss an NDA from Aegerion for lomitapide to treat...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >